{"id":59480,"date":"2024-06-04T16:02:24","date_gmt":"2024-06-04T14:02:24","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/teledyne-completes-acquisition-of-adimec\/"},"modified":"2024-06-04T16:02:24","modified_gmt":"2024-06-04T14:02:24","slug":"teledyne-completes-acquisition-of-adimec","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/teledyne-completes-acquisition-of-adimec\/","title":{"rendered":"Teledyne Completes Acquisition of Adimec"},"content":{"rendered":"
\n

THOUSAND OAKS, Calif.–(BUSINESS WIRE)–Teledyne Technologies Incorporated (NYSE:TDY) (\u201cTeledyne\u201d) announced today the successful completion of the previously announced acquisition of Adimec Holding B.V. and its subsidiaries (\u201cAdimec\u201d). Adimec, founded in 1992 and headquartered in Eindhoven, Netherlands, develops customized high-performance industrial and scientific cameras for applications where image quality is of paramount importance. Terms of the transaction were not disclosed.<\/p>\n

<\/a>
<\/a><\/p>\n

\n\u201cIn focus areas ranging from life sciences to semiconductor inspection, Adimec has grown to become a leader in niche applications requiring truly accurate images for precise decision making in time-critical processes,\u201d said Edwin Roks, Chief Executive Officer of Teledyne. \u201cWe are excited to welcome Adimec and its employees to Teledyne.\u201d<\/p>\n

\nAbout Teledyne<\/b><\/p>\n

\nTeledyne is a leading provider of sophisticated digital imaging products and software, instrumentation, aerospace and defense electronics, and engineered systems. Teledyne\u2019s operations are primarily located in the United States, Canada, the United Kingdom, and Western and Northern Europe. For more information, visit Teledyne\u2019s website at www.teledyne.com<\/a>.<\/p>\n

\nForward-Looking Statements Cautionary Notice<\/b><\/p>\n

\nThis press release contains forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995, relating to an acquisition of a company. Actual results could differ materially from these forward-looking statements. Many factors, as well as market and economic conditions beyond either company\u2019s control, could change anticipated results. There are additional risks associated with operating businesses internationally, including those arising from United States and foreign government policy and regulatory changes or actions and exchange rate fluctuations.<\/p>\n

Contacts<\/b> <\/p>\n

\nJason VanWees
\n
(805) 373-4542<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

THOUSAND OAKS, Calif.–(BUSINESS WIRE)–Teledyne Technologies Incorporated (NYSE:TDY) (\u201cTeledyne\u201d) announced today the successful completion of the previously announced acquisition of Adimec Holding B.V. and its subsidiaries (\u201cAdimec\u201d). Adimec, founded in 1992 and headquartered in Eindhoven, Netherlands, develops customized high-performance industrial and scientific cameras for applications where image quality is of paramount importance. Terms of the transaction … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-59480","6":"format-standard","7":"category-industry"},"yoast_head":"\nTeledyne Completes Acquisition of Adimec - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/teledyne-completes-acquisition-of-adimec\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Teledyne Completes Acquisition of Adimec - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"THOUSAND OAKS, Calif.–(BUSINESS WIRE)–Teledyne Technologies Incorporated (NYSE:TDY) (\u201cTeledyne\u201d) announced today the successful completion of the previously announced acquisition of Adimec Holding B.V. and its subsidiaries (\u201cAdimec\u201d). Adimec, founded in 1992 and headquartered in Eindhoven, Netherlands, develops customized high-performance industrial and scientific cameras for applications where image quality is of paramount importance. Terms of the transaction ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/teledyne-completes-acquisition-of-adimec\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2024-06-04T14:02:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20240604894510\/en\/765215\/22\/Teledyne_Technologies_w_Tag_Black_Blue_COLOR.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/teledyne-completes-acquisition-of-adimec\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/teledyne-completes-acquisition-of-adimec\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Teledyne Completes Acquisition of Adimec\",\"datePublished\":\"2024-06-04T14:02:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/teledyne-completes-acquisition-of-adimec\\\/\"},\"wordCount\":255,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/teledyne-completes-acquisition-of-adimec\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240604894510\\\/en\\\/765215\\\/22\\\/Teledyne_Technologies_w_Tag_Black_Blue_COLOR.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/teledyne-completes-acquisition-of-adimec\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/teledyne-completes-acquisition-of-adimec\\\/\",\"name\":\"Teledyne Completes Acquisition of Adimec - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/teledyne-completes-acquisition-of-adimec\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/teledyne-completes-acquisition-of-adimec\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240604894510\\\/en\\\/765215\\\/22\\\/Teledyne_Technologies_w_Tag_Black_Blue_COLOR.jpg\",\"datePublished\":\"2024-06-04T14:02:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/teledyne-completes-acquisition-of-adimec\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/teledyne-completes-acquisition-of-adimec\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/teledyne-completes-acquisition-of-adimec\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240604894510\\\/en\\\/765215\\\/22\\\/Teledyne_Technologies_w_Tag_Black_Blue_COLOR.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240604894510\\\/en\\\/765215\\\/22\\\/Teledyne_Technologies_w_Tag_Black_Blue_COLOR.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/teledyne-completes-acquisition-of-adimec\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Teledyne Completes Acquisition of Adimec\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Teledyne Completes Acquisition of Adimec - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/teledyne-completes-acquisition-of-adimec\/","og_locale":"en_US","og_type":"article","og_title":"Teledyne Completes Acquisition of Adimec - Pharma Trend","og_description":"THOUSAND OAKS, Calif.–(BUSINESS WIRE)–Teledyne Technologies Incorporated (NYSE:TDY) (\u201cTeledyne\u201d) announced today the successful completion of the previously announced acquisition of Adimec Holding B.V. and its subsidiaries (\u201cAdimec\u201d). Adimec, founded in 1992 and headquartered in Eindhoven, Netherlands, develops customized high-performance industrial and scientific cameras for applications where image quality is of paramount importance. Terms of the transaction ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/teledyne-completes-acquisition-of-adimec\/","og_site_name":"Pharma Trend","article_published_time":"2024-06-04T14:02:24+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20240604894510\/en\/765215\/22\/Teledyne_Technologies_w_Tag_Black_Blue_COLOR.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/teledyne-completes-acquisition-of-adimec\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/teledyne-completes-acquisition-of-adimec\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Teledyne Completes Acquisition of Adimec","datePublished":"2024-06-04T14:02:24+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/teledyne-completes-acquisition-of-adimec\/"},"wordCount":255,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/teledyne-completes-acquisition-of-adimec\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240604894510\/en\/765215\/22\/Teledyne_Technologies_w_Tag_Black_Blue_COLOR.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/teledyne-completes-acquisition-of-adimec\/","url":"https:\/\/pharma-trend.com\/en\/teledyne-completes-acquisition-of-adimec\/","name":"Teledyne Completes Acquisition of Adimec - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/teledyne-completes-acquisition-of-adimec\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/teledyne-completes-acquisition-of-adimec\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240604894510\/en\/765215\/22\/Teledyne_Technologies_w_Tag_Black_Blue_COLOR.jpg","datePublished":"2024-06-04T14:02:24+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/teledyne-completes-acquisition-of-adimec\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/teledyne-completes-acquisition-of-adimec\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/teledyne-completes-acquisition-of-adimec\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20240604894510\/en\/765215\/22\/Teledyne_Technologies_w_Tag_Black_Blue_COLOR.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20240604894510\/en\/765215\/22\/Teledyne_Technologies_w_Tag_Black_Blue_COLOR.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/teledyne-completes-acquisition-of-adimec\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Teledyne Completes Acquisition of Adimec"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/59480","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=59480"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/59480\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=59480"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=59480"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=59480"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}